COX Nicox SA

Nicox Announces 2020 Financial Results and 2021 Key Milestones

Nicox Announces 2020 Financial Results and 2021 Key Milestones

Press Release
Nicox Announces 2020 Financial Results and 2021 Key Milestones
  • Net revenue1 of €12.9 million in 2020 almost doubled versus 2019
  • Cash position increased to €47.2 million as of December 31, 2020
March 1st, 2021 – release at 7:30 am CET

Sophia Antipolis, France



Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, today announced the financial and operating results for Nicox and its subsidiaries (the “Nicox Group”) for the year ended December 31, 2020, as approved by the Board of Directors on February 26, 2021, and provided upcoming 2021 key milestones.



2020 Financial Summary



 



Net revenue1 for the full year 2020 was €12.9 million (€2.4 million in net royalties, €10.5 million in license payments), compared to €6.9 million (€2.1 million in net royalties, €4.8 million in upfront and milestone payments) for the full year 2019.  Net revenue has been revised upwards from that reported in the Q4 2020 business update due to an accounting adjustment reflecting a non-cash item of deferred income received from O